1-2 (They are also known to cause hair loss, tachycardia, hypoglycemia, diarrhea and/or constipation, nausea and vomiting, gastroparesis, bowel obstructions, thyroid C-cell tumors, acute kidney injuries, gallbladder problems and pancreatitis.) 3-4 A 2025 case study highlights a healthy patient who, after a month of liraglutide therapy, developed NAION despite lacking common cardiovascular risk factors, underscoring that this adverse effect can manifest even in low-risk individuals
PMID: 37599699
[55] There are clinical guidelines specifically to mitigate this risk in its use, [58] with doses limited to 510 mg orally before meals and at bedtime
KH: Writing review & editing
Always consult a licensed healthcare provider before starting any option
Discuss your risk factors